INTS
Intensity Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website intensitytherapeutics.com
- Employees(FY) -
- ISIN US45828J1034
Performance
+30.05%
1W
+19.27%
1M
+63.0%
3M
+132.86%
6M
-42.94%
YTD
-17.95%
1Y
Profile
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. Its lead product candidate includes INT230-6, a clinical trial for the treatment of refractory solid tumors and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. The company was incorporated in 2012 and is headquartered in Westport, Connecticut.
Technical Analysis of INTS 2024-05-10
Overview:
In analyzing the technical indicators for INTS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Indicators:
- Moving Averages (MA): The 5-day MA has been below the closing price, indicating a s...
Recent News & Updates
- 2024-05-14 20:01
- 2024-05-09 22:48
- 2024-05-09 20:01
- 2024-05-09 11:54
- 2024-05-09 04:08
- 2024-04-01 20:01
- 2024-03-26 11:53
- 2024-03-25 20:01
- 2024-03-14 04:09
- 2024-03-13 20:00
- 2024-02-20 19:01
- 2024-01-02 19:01
- 2023-12-11 19:01
- 2023-12-07 22:12
Why Is Intensity Therapeutics (INTS) Stock Up 133% Today?(Investorplace)
- 2023-12-07 19:30
- 2023-11-30 19:01
- 2023-11-12 19:01
- 2023-11-01 19:01
- 2023-09-06 20:01
- 2023-09-04 20:01
- 2023-08-13 19:01
- 2023-08-06 19:01
- 2023-07-31 04:05
- 2023-07-09 20:00
- 2023-07-05 04:15
- 2023-06-29 08:00
Page 1 of 1
previousnext